Journal Home
Search for

Volume 65, Issue 10, Pages 835-840 (15 May 2009)


View previous. 9 of 22 View next.

Amphetamine-Induced Changes in Dendritic Morphology in Rat Forebrain Correspond to Associative Drug Conditioning Rather than Nonassociative Drug Sensitization

Bryan F. Singera, Lauren M. Tanabec, Grazyna Gornyd, Charmaine Jake-Matthewsb, Yilin Lid, Bryan Kolbd, Paul VezinaabCorresponding Author Informationemail address

Received 25 November 2008; received in revised form 18 December 2008; accepted 19 December 2008. published online 06 February 2009.

Background

Systemic exposure to amphetamine (AMPH) leads to a number of long-lasting neuroadaptations including changes in dendritic morphology in rat forebrain. It remains unknown whether these changes relate to associative drug conditioning or to nonassociative drug sensitization, two forms of plasticity produced by systemic exposure to AMPH.

Methods

We compared the behavioral, neuronal, and morphologic consequences of exposing rats to intraperitoneal (IP) AMPH to those of exposure to AMPH applied to the ventral tegmental area (VTA), infusions that sensitize AMPH-induced locomotion and nucleus accumbens (NAcc) DA overflow but do not produce drug conditioning.

Results

Both IP and VTA AMPH exposure sensitized locomotion and NAcc DA overflow, but only IP AMPH exposure produced conditioned locomotion. Importantly, whereas IP AMPH exposure increased spine density and dendritic length and branching in the NAcc, exposure to VTA AMPH produced the opposite effects. A similar differentiation of effects was observed in cortical areas.

Conclusions

Together these findings suggest that the morphological changes seen following IP AMPH exposure reflect associative drug conditioning rather than nonassociative drug sensitization. The decreases observed in the NAcc of VTA AMPH exposed rats may reflect the inability of these infusions to support conditioning.

a Committee on Neurobiology, The University of Chicago, Chicago, Illinois

b Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois

c Department of Pharmacology, Columbia University, New York, New York

d Department of Neuroscience, University of Lethbridge, Lethbridge, Canada

Corresponding Author InformationAddress reprint requests to Paul Vezina, Ph.D., Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, 5841 S. Maryland Avenue, MC 3077, Chicago, IL 60637

PII: S0006-3223(08)01600-4

doi:10.1016/j.biopsych.2008.12.020


View previous. 9 of 22 View next.